Related Experiment Video
Updated: Dec 22, 2025

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Management of a patient presenting with giant cell myocarditis - A case report
Nisarg Patel1, Nishank Nooli1, Linda Sundt1
1Department of Anesthesiology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Abstract:
Giant cell myocarditis is a rare and frequently fatal disease that requires extensive cardiac care. Given the rarity of this condition no specific management recommendations exist. We describe a patient who presented with congestive heart failure that required a left ventricular assist device and a temporary right ventricular assist device along with immunosuppressive therapy. This case also brings to attention how undocumented immigration status can limit transplantation opportunities in the USA. <Learning objective: Giant cell myocarditis is a rare and frequently fatal cardiac disease that, until the 1980s, was only diagnosed during autopsy. It is commonly seen in young and middle-aged, otherwise healthy, individuals with median transplant-free survival of 5.5 months from diagnosis. Current treatments with immunosuppressant medications do not seem to be significantly effective. Most patients require transplant or ventricular assist device for survival.>.
Related Concept Videos
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
